BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 29217931)

  • 21. Hyperparathyroidism-jaw Tumor Syndrome: An Overlooked Cause of Severe Hypercalcemia.
    Mathews JW; Winchester R; Alsaygh N; Bartlett AM; Luttrell L
    Am J Med Sci; 2016 Sep; 352(3):302-5. PubMed ID: 27650236
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A large extended family with hyperparathyroidism-jaw tumor syndrome due to deletion of the third exon of CDC73: clinical and molecular features.
    Le Collen L; Barraud S; Braconnier A; Coppin L; Zachar D; Boulagnon C; Deguelte S; Souchon PF; Spodenkiewicz M; Poirsier C; Aubert S; Odou MF; Delemer B
    Endocrine; 2021 Sep; 73(3):693-701. PubMed ID: 33999366
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A genotypic and histopathological study of a large Dutch kindred with hyperparathyroidism-jaw tumor syndrome.
    Haven CJ; Wong FK; van Dam EW; van der Juijt R; van Asperen C; Jansen J; Rosenberg C; de Wit M; Roijers J; Hoppener J; Lips CJ; Larsson C; Teh BT; Morreau H
    J Clin Endocrinol Metab; 2000 Apr; 85(4):1449-54. PubMed ID: 10770180
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Benign polypoid adenomyomatous endometrium associated with hpt-JT syndrome: a case report.
    Arfi A; Chabbert-Buffet N; Boudy AS; de Foucher T; Owen C; Bendifallah S; Darai E
    Gynecol Endocrinol; 2020 Jan; 36(1):30-32. PubMed ID: 31429335
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel CDC73 gene mutation in an Italian family with hyperparathyroidism-jaw tumour (HPT-JT) syndrome.
    Chiofalo MG; Sparaneo A; Chetta M; Franco R; Baorda F; Cinque L; Granatiero M; D'Agruma L; Pezzullo L; Scillitani A; Guarnieri V
    Cell Oncol (Dordr); 2014 Aug; 37(4):281-8. PubMed ID: 25113791
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical, genetic, and histopathologic investigation of CDC73-related familial hyperparathyroidism.
    Masi G; Barzon L; Iacobone M; Viel G; Porzionato A; Macchi V; De Caro R; Favia G; Palù G
    Endocr Relat Cancer; 2008 Dec; 15(4):1115-26. PubMed ID: 18755853
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association Between Parafibromin Expression and Presence of Brown Tumors and Jaw Tumors in Patients with Primary Hyperparathyroidism: Series of Cases with Review of the Literature.
    Popow M; Kaszczewska M; Góralska M; Kaszczewski P; Skwarek-Szewczyk A; Chudziński W; Jażdżewski K; Kolanowska M; Bogdańska M; Starzyńska-Kubicka A; Gałązka Z
    Am J Case Rep; 2022 Oct; 23():e936135. PubMed ID: 36271606
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [CDC73 mutations in young patients with primary hyperparathyroidism: A description of two clinical cases].
    Mamedova EO; Mokrysheva NG; Pigarova EA; Przhiyalkovskaya EG; Voronkova IA; Vasilyev EV; Petrov VM; Gorbunova VA; Rozhinskaya LY; Belaya ZE; Tyulpakov AN
    Ter Arkh; 2016; 88(10):57-62. PubMed ID: 27801421
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Loss of nuclear expression of parafibromin distinguishes parathyroid carcinomas and hyperparathyroidism-jaw tumor (HPT-JT) syndrome-related adenomas from sporadic parathyroid adenomas and hyperplasias.
    Gill AJ; Clarkson A; Gimm O; Keil J; Dralle H; Howell VM; Marsh DJ
    Am J Surg Pathol; 2006 Sep; 30(9):1140-9. PubMed ID: 16931959
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hyperparathyroidism-jaw tumor syndrome: a report of three large kindred.
    Iacobone M; Masi G; Barzon L; Porzionato A; Macchi V; Ciarleglio FA; Palù G; De Caro R; Viel G; Favia G
    Langenbecks Arch Surg; 2009 Sep; 394(5):817-25. PubMed ID: 19529956
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cell division cycle protein 73 homolog (CDC73) mutations in the hyperparathyroidism-jaw tumor syndrome (HPT-JT) and parathyroid tumors.
    Newey PJ; Bowl MR; Cranston T; Thakker RV
    Hum Mutat; 2010 Mar; 31(3):295-307. PubMed ID: 20052758
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular genetics of syndromic and non-syndromic forms of parathyroid carcinoma.
    Cardoso L; Stevenson M; Thakker RV
    Hum Mutat; 2017 Dec; 38(12):1621-1648. PubMed ID: 28881068
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic analyses in patients with familial isolated hyperparathyroidism and hyperparathyroidism-jaw tumour syndrome.
    Mizusawa N; Uchino S; Iwata T; Tsuyuguchi M; Suzuki Y; Mizukoshi T; Yamashita Y; Sakurai A; Suzuki S; Beniko M; Tahara H; Fujisawa M; Kamata N; Fujisawa K; Yashiro T; Nagao D; Golam HM; Sano T; Noguchi S; Yoshimoto K
    Clin Endocrinol (Oxf); 2006 Jul; 65(1):9-16. PubMed ID: 16817812
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-Term Outcomes of Parathyroidectomy in Hyperparathyroidism-Jaw Tumor Syndrome: Analysis of Five Families with CDC73 Mutations.
    Iacobone M; Camozzi V; Mian C; Pennelli G; Pagetta C; Casal Ide E; Masi G; Zovato S; Torresan F
    World J Surg; 2020 Feb; 44(2):508-516. PubMed ID: 31493194
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Familial isolated primary hyperparathyroidism/hyperparathyroidism-jaw tumour syndrome caused by germline gross deletion or point mutations of CDC73 gene in Chinese.
    Kong J; Wang O; Nie M; Shi J; Hu Y; Jiang Y; Li M; Xia W; Meng X; Xing X
    Clin Endocrinol (Oxf); 2014 Aug; 81(2):222-30. PubMed ID: 24716902
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Frequent large germline HRPT2 deletions in a French National cohort of patients with primary hyperparathyroidism.
    Bricaire L; Odou MF; Cardot-Bauters C; Delemer B; North MO; Salenave S; Vezzosi D; Kuhn JM; Murat A; Caron P; Sadoul JL; Silve C; Chanson P; Barlier A; Clauser E; Porchet N; Groussin L;
    J Clin Endocrinol Metab; 2013 Feb; 98(2):E403-8. PubMed ID: 23293331
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 18F-FDG PET/CT in the Hyperparathyroidism-Jaw-Tumor Syndrome.
    Nazerani Hooshmand T; Pernthaler B; Szurian K; Pau M; Aigner RM
    Clin Nucl Med; 2021 Jun; 46(6):497-498. PubMed ID: 33826572
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Primary hyperparathyroidism and jaw tumor syndrome: a novel mutation of the HRPT2 gene.
    Carlson AL; Smith CL
    Endocr Pract; 2008 Sep; 14(6):743-7. PubMed ID: 18996796
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HRPT2- (CDC73) RELATED HEREDITARY HYPERPARATHYROIDISM: A CASE SERIES FROM WESTERN INDIA.
    Khadilkar KS; Budyal SR; Kasliwal R; Lila AR; Bandgar T; Shah NS
    Endocr Pract; 2015 Sep; 21(9):1010-6. PubMed ID: 26121439
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification and functional characterization of three NoLS (nucleolar localisation signals) mutations of the CDC73 gene.
    Pazienza V; la Torre A; Baorda F; Alfarano M; Chetta M; Muscarella LA; Battista C; Copetti M; Kotzot D; Kapelari K; Al-Abdulrazzaq D; Perlman K; Sochett E; Cole DE; Pellegrini F; Canaff L; Hendy GN; D'Agruma L; Zelante L; Carella M; Scillitani A; Guarnieri V
    PLoS One; 2013; 8(12):e82292. PubMed ID: 24340015
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.